Launch week offerEnds in00h00m00s

annual Promonthly Pro

Nadim Mahmud

Professor

University of Illinois Chicago (UIC)

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States Professors in Cell Biology Cell Biology professors in United States

About

Dr. Nadim Mahmud is an Assistant Professor at the Hospital of the University of Pennsylvania, USA. His research focuses on posttransplant outcomes, particularly in the context of COVID-19-positive deceased donor liver transplantation, as well as the stability of cryopreserved hematopoietic stem and progenitor cells. Dr. Mahmud's work contributes significantly to the field of cellular therapy and transplantation.

Articles (13)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2022

Collaborators (8)

Sally Campbell‐Lee

University of Illinois Chicago (UIC)

UNITED STATES

View details

University of Illinois Chicago (UIC)

UNITED STATES

View details

Paul Rubinstein

Attending Physician/Visiting Associate Professor

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nadim Mahmud

Research Interests

Make your next move.

Explore related searches

About

Articles (13)

Renin-angiotensin-aldosterone system inhibition exacerbates anemia in sickle cell disease

Beyond body weight: investigating the impact of body surface area on graft CD34+ cell dosing: a single-center experience

The evolving role of umbilical cord blood in transplantation, immunotherapy, and regenerative medicine: a brief contemporary review by the ISCT lab practices committee

Regulatory Ambiguity in Hematopoietic Cell Transplantation in India: A National Survey

Revisiting Allogeneic Hematopoietic Cell Donor Selection Guidelines: Umbilical Cord Blood in the PTCy Era

Valproic acid-expanded cord blood CD34+CD90+ cells are functionally distinct based on their origin

Global blood and marrow transplantation training for international physicians from LMICs: 5-year experience at UIC

Intensified conditioning with high-dose total marrow irradiation and myeloablative chemotherapy reduces risk of relapse without increasing toxicity in allogeneic hematopoietic stem cell transplant for high-risk myeloid malignancies: a phase II study.

Safety of subconjunctival injection of mesenchymal stromal cells in persistent corneal epithelial disease - A phase 1b clinical trial.

Shaping the future of cell and gene therapy workforce development: training of cell therapy processing personnel - perspectives from the International Society for Cell & Gene Therapy Lab Practices Committee.

Posttransplant outcomes and trends in use of COVID-19-positive deceased donor liver transplantation

Posttransplant outcomes and trends in use of COVID-19-positive deceased donor liver transplantation

Cryopreserved hematopoietic stem/progenitor cells stability program‐development, current status and recommendations: A brief report from the AABB‐ISCT joint working group cellular therapy product stability project team

Collaborators (8)

Sally Campbell‐Lee

Carlos Galvez

john quigley

Sujata Gaitonde

Punam Malik

Charles Quinn

Charlotte Joslin

Paul Rubinstein

Make your next move.

Nadim Mahmud

Research Interests

Make your next move.

Explore related searches

About

Articles (13)

Renin-angiotensin-aldosterone system inhibition exacerbates anemia in sickle cell disease

Beyond body weight: investigating the impact of body surface area on graft CD34+ cell dosing: a single-center experience

The evolving role of umbilical cord blood in transplantation, immunotherapy, and regenerative medicine: a brief contemporary review by the ISCT lab practices committee

Regulatory Ambiguity in Hematopoietic Cell Transplantation in India: A National Survey

Revisiting Allogeneic Hematopoietic Cell Donor Selection Guidelines: Umbilical Cord Blood in the PTCy Era

Valproic acid-expanded cord blood CD34+CD90+ cells are functionally distinct based on their origin

Global blood and marrow transplantation training for international physicians from LMICs: 5-year experience at UIC

Intensified conditioning with high-dose total marrow irradiation and myeloablative chemotherapy reduces risk of relapse without increasing toxicity in allogeneic hematopoietic stem cell transplant for high-risk myeloid malignancies: a phase II study.

Safety of subconjunctival injection of mesenchymal stromal cells in persistent corneal epithelial disease - A phase 1b clinical trial.

Shaping the future of cell and gene therapy workforce development: training of cell therapy processing personnel - perspectives from the International Society for Cell &amp; Gene Therapy Lab Practices Committee.

Posttransplant outcomes and trends in use of COVID-19-positive deceased donor liver transplantation

Posttransplant outcomes and trends in use of COVID-19-positive deceased donor liver transplantation

Cryopreserved hematopoietic stem/progenitor cells stability program‐development, current status and recommendations: A brief report from the AABB‐ISCT joint working group cellular therapy product stability project team

Collaborators (8)

Sally Campbell‐Lee

Carlos Galvez

john quigley

Sujata Gaitonde

Punam Malik

Charles Quinn

Charlotte Joslin

Paul Rubinstein

Make your next move.

Shaping the future of cell and gene therapy workforce development: training of cell therapy processing personnel - perspectives from the International Society for Cell & Gene Therapy Lab Practices Committee.